How do novel molecular genetic markers influence treatment decisions in acute myeloid leukemia?

Abstract excerpt

Acute myeloid leukemia (AML) is the most common acute leukemia diagnosed in adults, and the majority of patients with AML die from relapsed disease. Although many studies over the past 4 decades have identified disease alleles in AML, recent genome-wide and candidate gene studies have identified additional recurrent somatic mutations in AML patients with biologic, clinical, and therapeutic importance. Herein we...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Daunorubicin
• Share to Dioxygenases
• Share to DNA (Cytosine-5-)-Methyltransferases